| Navpreet Marwaha, PHARMD | |
|
3614 Mt Diablo Blvd, Lafayette, CA 94549-3737 | |
| (925) 385-2385 | |
| Not Available |
| Full Name | Navpreet Marwaha |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3614 Mt Diablo Blvd, Lafayette, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801177993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 72443 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Navpreet Marwaha, PHARMD 3614 Mt Diablo Blvd, Lafayette, CA 94549-3737 Ph: (925) 385-2385 | Navpreet Marwaha, PHARMD 3614 Mt Diablo Blvd, Lafayette, CA 94549-3737 Ph: (925) 385-2385 |
News Archive
Eli Lilly and Company today announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced the U. S. launch of Synera.
A Dartmouth research laboratory is working to quantify the effects of playing games. In a study published online last month by the Games for Health Journal, Professor Mary Flanagan and her team found that attitudes toward public health issues shift to be more accepting and understanding after playing a game they developed called RePlay Health.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.
› Verified 3 days ago
Vincent Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3625 Mt Diablo Blvd, Lafayette, CA 94549 Phone: 925-284-7121 Fax: 925-284-2056 | |
Melanie Vela, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3540 Mt Diablo Blvd, Lafayette, CA 94549 Phone: 925-284-1550 | |
Mr. Christopher T Oyoung, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3540 Mt Diablo Blvd, Lafayette, CA 94549 Phone: 925-284-1550 Fax: 925-284-9202 | |
Jamie Kaya, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3625 Mt Diablo Blvd, Lafayette, CA 94549 Phone: 925-284-7121 | |
Silvia Isel Hernandez, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3540 Mt Diablo Blvd, Lafayette, CA 94549 Phone: 925-284-1550 Fax: 925-284-9202 | |
Shima Novin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3625 Mt Diablo Blvd, Lafayette, CA 94549 Phone: 925-284-7121 | |
Satinder Kaur Sheena, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3625 Mt Diablo Blvd, Lafayette, CA 94549 Phone: 925-284-7121 |